JERAX
Price
$13.16
Change
+$0.07 (+0.53%)
Updated
Jun 11 closing price
Net Assets
339.13M
MGLCX
Price
$17.66
Change
+$0.18 (+1.03%)
Updated
Jun 12 closing price
Net Assets
2.17B
Interact to see
Advertisement

JERAX vs MGLCX

Header iconJERAX vs MGLCX Comparison
Open Charts JERAX vs MGLCXBanner chart's image
JERAX vs MGLCX Comparison Chart in %
View a ticker or compare two or three
VS
JERAX vs. MGLCX commentary
Jun 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JERAX is a Hold and MGLCX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
MGLCX has more cash in the bank: 2.17B vs. JERAX (339M). JERAX pays higher dividends than MGLCX: JERAX (2.78) vs MGLCX (1.93). JERAX was incepted earlier than MGLCX: JERAX (19 years) vs MGLCX (11 years). MGLCX (1.94) is less costly to investors than JERAX (0.99). JERAX is a more actively managed with annual turnover of: 61.00 vs. MGLCX (35.00). MGLCX has a lower initial minimum investment than JERAX: MGLCX (1000) vs JERAX (2500). JERAX annual gain was more profitable for investors over the last year : 12.84 vs. MGLCX (7.42). JERAX return over 5 years is better than : -3.10 vs. MGLCX (-12.19).
JERAXMGLCXJERAX / MGLCX
Total Expense Ratio0.991.9351%
Annual Report Gross Expense Ratio0.991.9451%
Fund Existence19 years11 years-
Gain YTD9.5948.035119%
Front Load6%N/A-
Min. Initial Investment25001000250%
Min. Initial Investment IRAN/AN/A-
Net Assets339M2.17B16%
Annual Yield % from dividends2.781.93144%
Returns for 1 year12.847.42173%
Returns for 3 years26.4815.47171%
Returns for 5 years-3.10-12.1925%
Returns for 10 years64.9319.58332%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
STKE1.270.06
+5.37%
Sol Strategies Inc
CAMT193.279.12
+4.95%
Camtek Ltd
DCOM40.080.27
+0.68%
Dime Commercial Bancshares, Inc.
OXLCN24.930.01
+0.04%
Oxford Lane Capital Corp
LRMR3.47-0.13
-3.61%
Larimar Therapeutics